Back to VANGUARD GROUP INC VANGUARD GROUP INC

TGTXTGTX
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in TG Therapeutics, Inc.

VANGUARD GROUP INC holds 15.8M shares of TGTX (TG Therapeutics, Inc.), worth $472.2M as of 2025-Q4. The position was increased (+2.1% shares). TGTX represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$472.2M

Current Shares

15.8M

Total Value Change

+$112.3M

Total Shares Change

+453,712

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
15.8M
+2.1%
$472.2M0.0%$29.75
32
2025-Q3
Decreased
15.5M
-1.8%
$560.7M0.0%$36.83
0
2025-Q2
Increased
15.8M
+1.3%
$569M0.0%$36.72
32
2025-Q1
Increased
15.6M
+0.1%
$615.3M0.0%$39.86
31
2024-Q4
Increased
15.6M
+1.4%
$469.5M0.0%$31.44
32
2024-Q3
New
15.4M
-
$359.9M0.0%$23.83
43

Other major holders of TGTX: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used